Physician profile
Molly A Larkin
NPI 1063443133
$933.27
in general payments reported to CMS, 2019-2025
18 companies · $278 in 2025
The $278 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $11.90 · 2021: $25.24 · 2022: $56.09 · 2023: $164 · 2024: $276 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $352.80 | 2023-2025 | Desara |
| Abbvie INC. | $135.53 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $59.06 | 2025 | Myfembree |
| Daiichi Sankyo INC. | $52.74 | 2019-2022 | |
| Astellas Pharma US INC | $51.78 | 2024-2025 | Veozah |
| Davol INC. | $42.98 | 2025 | Arista |
| Amgen INC. | $30.43 | 2023 | Evenity, Prolia |
| Organon LLC | $28.82 | 2025 | Nexplanon |
| Evofem Biosciences, INC. | $24.99 | 2024 | |
| Exeltis, USA INC. | $23.65 | 2020-2022 | |
| Pfizer INC. | $21.77 | 2024 | |
| Millicent US INC | $19.85 | 2025 | Femlyv, Intrarosa |
| Minerva Surgical, INC | $18.82 | 2025 | |
| Therapeuticsmd, INC. | $16.98 | 2019 | |
| Coopersurgical, INC. | $15.00 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $14.21 | 2019 | |
| Allergan, INC. | $12.84 | 2019 | |
| Alydia Health | $11.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Larkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.